-
1
-
-
58549118043
-
Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence
-
Koenig W., and Khuseyinova N. Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence. Cardiovasc Drugs Ther 23 1 (2009) 85-92
-
(2009)
Cardiovasc Drugs Ther
, vol.23
, Issue.1
, pp. 85-92
-
-
Koenig, W.1
Khuseyinova, N.2
-
2
-
-
72949102004
-
Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease
-
Koenig W., Vossen C.Y., Mallat Z., Brenner H., Benessiano J., and Rothenbacher D. Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. Eur Heart J 30 22 (2009) 2742-2748
-
(2009)
Eur Heart J
, vol.30
, Issue.22
, pp. 2742-2748
-
-
Koenig, W.1
Vossen, C.Y.2
Mallat, Z.3
Brenner, H.4
Benessiano, J.5
Rothenbacher, D.6
-
3
-
-
58549103715
-
Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease
-
Rosenson R.S. Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease. Cardiovasc Drugs Ther 23 1 (2009) 93-101
-
(2009)
Cardiovasc Drugs Ther
, vol.23
, Issue.1
, pp. 93-101
-
-
Rosenson, R.S.1
-
4
-
-
70350022227
-
Opposite effects of native and oxidized lipoproteins on the activity of secretory phospholipase A(2) group IIA
-
Korotaeva A.A., Samoilova E.V., Pirkova A.A., et al. Opposite effects of native and oxidized lipoproteins on the activity of secretory phospholipase A(2) group IIA. Prostaglandins Lipid Mediat 90 1-2 (2009) 37-41
-
(2009)
Prostaglandins Lipid Mediat
, vol.90
, Issue.1-2
, pp. 37-41
-
-
Korotaeva, A.A.1
Samoilova, E.V.2
Pirkova, A.A.3
-
5
-
-
84863495004
-
The role of oxidized phospholipids in atherosclerosis
-
Berliner J.A., Leitinger N., and Tsimikas S. The role of oxidized phospholipids in atherosclerosis. J Lipid Res 50 Suppl. (2009) S207-S212
-
(2009)
J Lipid Res
, vol.50
, Issue.SUPPL
-
-
Berliner, J.A.1
Leitinger, N.2
Tsimikas, S.3
-
6
-
-
59449096216
-
Novel aspects of oxidative stress in cardiovascular diseases
-
Heistad D.D., Wakisaka Y., Miller J., Chu Y., and Pena-Silva R. Novel aspects of oxidative stress in cardiovascular diseases. Circ J 73 2 (2009) 201-207
-
(2009)
Circ J
, vol.73
, Issue.2
, pp. 201-207
-
-
Heistad, D.D.1
Wakisaka, Y.2
Miller, J.3
Chu, Y.4
Pena-Silva, R.5
-
7
-
-
28444431551
-
Oxidized phospholipids as triggers of inflammation in atherosclerosis
-
Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res 49 11 (2005) 1063-1071
-
(2005)
Mol Nutr Food Res
, vol.49
, Issue.11
, pp. 1063-1071
-
-
Leitinger, N.1
-
8
-
-
62349112779
-
Oxidized phospholipids in control of inflammation and endothelial barrier
-
Fu P., and Birukov K.G. Oxidized phospholipids in control of inflammation and endothelial barrier. Transl Res 153 4 (2009) 166-176
-
(2009)
Transl Res
, vol.153
, Issue.4
, pp. 166-176
-
-
Fu, P.1
Birukov, K.G.2
-
9
-
-
63649134360
-
Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration
-
Cherepanova O.A., Pidkovka N.A., Sarmento O.F., et al. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res 104 5 (2009) 609-618
-
(2009)
Circ Res
, vol.104
, Issue.5
, pp. 609-618
-
-
Cherepanova, O.A.1
Pidkovka, N.A.2
Sarmento, O.F.3
-
10
-
-
0037064036
-
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions
-
Podrez E.A., Poliakov E., Shen Z., et al. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem 277 41 (2002) 38517-38523
-
(2002)
J Biol Chem
, vol.277
, Issue.41
, pp. 38517-38523
-
-
Podrez, E.A.1
Poliakov, E.2
Shen, Z.3
-
11
-
-
66149131879
-
Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial
-
Fraley A.E., Schwartz G.G., Olsson A.G., et al. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. J Am Coll Cardiol 53 23 (2009) 2186-2196
-
(2009)
J Am Coll Cardiol
, vol.53
, Issue.23
, pp. 2186-2196
-
-
Fraley, A.E.1
Schwartz, G.G.2
Olsson, A.G.3
-
12
-
-
33751171875
-
Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease
-
Tsimikas S. Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease. Am J Cardiol 98 11A (2006) 9P-17P
-
(2006)
Am J Cardiol
, vol.98
, Issue.11 A
-
-
Tsimikas, S.1
-
13
-
-
66549106094
-
Oxidized LDL, lipoprotein (a) and other emergent risk factors in acute myocardial infarction (FORTIAM study)
-
Gomez M., Valle V., Aros F., et al. Oxidized LDL, lipoprotein (a) and other emergent risk factors in acute myocardial infarction (FORTIAM study). Rev Esp Cardiol 62 4 (2009) 373-382
-
(2009)
Rev Esp Cardiol
, vol.62
, Issue.4
, pp. 373-382
-
-
Gomez, M.1
Valle, V.2
Aros, F.3
-
14
-
-
0030883811
-
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI
-
Koumanov K., Wolf C., and Bereziat G. Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI. Biochem J 326 Pt 1 (1997) 227-233
-
(1997)
Biochem J
, vol.326
, Issue.PART 1
, pp. 227-233
-
-
Koumanov, K.1
Wolf, C.2
Bereziat, G.3
-
16
-
-
33750933123
-
The interfacial binding surface of phospholipase A2s
-
Winget J.M., Pan Y.H., and Bahnson B.J. The interfacial binding surface of phospholipase A2s. Biochim Biophys Acta 1761 11 (2006) 1260-1269
-
(2006)
Biochim Biophys Acta
, vol.1761
, Issue.11
, pp. 1260-1269
-
-
Winget, J.M.1
Pan, Y.H.2
Bahnson, B.J.3
-
17
-
-
0037073750
-
Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2
-
Singer A.G., Ghomashchi F., Le Calvez C., et al. Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. J Biol Chem 277 50 (2002) 48535-48549
-
(2002)
J Biol Chem
, vol.277
, Issue.50
, pp. 48535-48549
-
-
Singer, A.G.1
Ghomashchi, F.2
Le Calvez, C.3
-
18
-
-
0030742997
-
Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2
-
Eckey R., Menschikowski M., Lattke P., and Jaross W. Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2. Atherosclerosis 132 2 (1997) 165-176
-
(1997)
Atherosclerosis
, vol.132
, Issue.2
, pp. 165-176
-
-
Eckey, R.1
Menschikowski, M.2
Lattke, P.3
Jaross, W.4
-
19
-
-
0031785119
-
Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL
-
Pruzanski W., Stefanski E., de Beer F.C., et al. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. J Lipid Res 39 11 (1998) 2150-2160
-
(1998)
J Lipid Res
, vol.39
, Issue.11
, pp. 2150-2160
-
-
Pruzanski, W.1
Stefanski, E.2
de Beer, F.C.3
-
20
-
-
30944447092
-
Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis
-
Kougias P., Chai H., Lin P.H., Lumsden A.B., Yao Q., and Chen C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 12 1 (2006) RA5-RA16
-
(2006)
Med Sci Monit
, vol.12
, Issue.1
-
-
Kougias, P.1
Chai, H.2
Lin, P.H.3
Lumsden, A.B.4
Yao, Q.5
Chen, C.6
|